These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
2. Obesity hypertension, salt sensitivity and insulin resistance. Rocchini AP Nutr Metab Cardiovasc Dis; 2000 Oct; 10(5):287-94. PubMed ID: 11213538 [TBL] [Abstract][Full Text] [Related]
3. Mechanisms of abnormal renal sodium handling in obesity hypertension. Hall JE Am J Hypertens; 1997 May; 10(5 Pt 2):49S-55S. PubMed ID: 9160781 [TBL] [Abstract][Full Text] [Related]
4. [New concepts in the pathogenesis of essential hypertension]. Zbroch E; Małyszko J; Myśliwiec M Przegl Lek; 1999; 56(4):281-5. PubMed ID: 10494165 [TBL] [Abstract][Full Text] [Related]
5. Diet, obesity and hypertension: an hypothesis involving insulin, the sympathetic nervous system, and adaptive thermogenesis. Landsberg L Q J Med; 1986 Dec; 61(236):1081-90. PubMed ID: 3310065 [No Abstract] [Full Text] [Related]
6. Pathophysiology of obesity-related hypertension: role of insulin and the sympathetic nervous system. Landsberg L J Cardiovasc Pharmacol; 1994; 23 Suppl 1():S1-8. PubMed ID: 7519690 [TBL] [Abstract][Full Text] [Related]
8. Sympathetic and renin-angiotensin systems contribute to increased blood pressure in sucrose-fed rats. Freitas RR; Lopes KL; Carillo BA; Bergamaschi CT; Carmona AK; Casarini DE; Furukawa L; Heimann JC; Campos RR; Dolnikoff MS Am J Hypertens; 2007 Jun; 20(6):692-8. PubMed ID: 17531930 [TBL] [Abstract][Full Text] [Related]
9. Sympathetic nervous system and hypertension in diabetic patients. Vecchione C; Argenziano L; Fratta L; Pompeo F; Trimarco B Diabetes Nutr Metab; 2000 Dec; 13(6):327-31. PubMed ID: 11232757 [TBL] [Abstract][Full Text] [Related]
10. Essential hypertension: A childhood disease? Reynolds JL J La State Med Soc; 1973 Feb; 125(2):53-8. PubMed ID: 4569194 [No Abstract] [Full Text] [Related]
11. Role of nutrition in hypertension and its control--experimental aspects. Dustan HP Prog Biochem Pharmacol; 1983; 19():177-91. PubMed ID: 6338522 [No Abstract] [Full Text] [Related]
12. Mineralocorticoid receptor activation in obesity hypertension. Nagase M; Fujita T Hypertens Res; 2009 Aug; 32(8):649-57. PubMed ID: 19521418 [TBL] [Abstract][Full Text] [Related]
13. Pathways from obesity to hypertension: from the perspective of a vicious triangle. Montani JP; Antic V; Yang Z; Dulloo A Int J Obes Relat Metab Disord; 2002 Sep; 26 Suppl 2():S28-38. PubMed ID: 12174326 [TBL] [Abstract][Full Text] [Related]
14. The possible mechanisms of alcohol associated hypertension. Potter JF; Beevers DG Ann Clin Res; 1984; 16 Suppl 43():97-102. PubMed ID: 6398988 [TBL] [Abstract][Full Text] [Related]
15. Obesity in hypertension: effects on prognosis and treatment. Kaplan NM J Hypertens Suppl; 1998 Jan; 16(1):S35-7. PubMed ID: 9534095 [TBL] [Abstract][Full Text] [Related]
17. Neuropeptide Y and alpha-melanocyte-stimulating hormone: interaction in obesity and possible role in the development of hypertension. Baltatzi M; Hatzitolios A; Tziomalos K; Iliadis F; Zamboulis Ch Int J Clin Pract; 2008 Sep; 62(9):1432-40. PubMed ID: 18793378 [TBL] [Abstract][Full Text] [Related]
18. [Hypertension in obesity]. Skórka B; Chlebus H Pol Tyg Lek; 1984 Apr; 39(15):513-7. PubMed ID: 6384963 [No Abstract] [Full Text] [Related]
19. Insulin and the sympathetic nervous system in the pathophysiology of hypertension. Landsberg L Blood Press Suppl; 1996; 1():25-9. PubMed ID: 9162434 [TBL] [Abstract][Full Text] [Related]
20. Hypertension and obesity after the menopause. Rappelli A J Hypertens Suppl; 2002 May; 20(2):S26-8. PubMed ID: 12183846 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]